C-F8NGBiotein
saliva assay, protein biomarkers, cellular damage
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-F8NG
C-F8NGC-F8NGsaliva assay, protein biomarkers, cellular damage
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Biotein saliva assay, protein biomarkers, cellular damage
Biotein is developing a saliva-based test intended to measure key protein markers associated with age-related cellular damage. The company says its test is designed to track health with age, including proteins involved with damage to mitochondria, telomeres, and cellular processes. Biotein states it is not detecting disease, but aims to provide a picture of health before disease strikes.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Biotein — Far from goals · Bottom quartile. Derived deterministically from 1 extracted project(s). Most-advanced status: exploratory. Band: far. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic